Neovasc Inc NVCN Fundamentals and Key Ratios

Neovasc Inc. (NVCN) Fundamentals


Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

SHARE INFORMATION
Market Cap	$ 80,486,418
Shares Outstanding	2,707,522
Float	2,746,171
Percent Float	99.53%
Short Interest	0.00
Short Percent Float	0.0%
Short Interest Ratio	0.00
Short Interest Date	-
Latest Fiscal Dividend Per Share	$ 0.00
Latest Fiscal Revenue	$ 2,368,450
Latest Fiscal EPS	$ 0.00
Latest Fiscal Date	2021-12-31

DIVIDENDS
Dividend (3 Years)	$ 0.00
Dividend (5 Years)	$ 0.00
Ex Dividend Date	-
Dividend Rate	$ 0.00
Dividend Yield	0.0%
Payment Cash	-

HOLDERS
Institutions	15
Institutional Holdings Date	2023-02-28
Institutional Bought Previous 3 Months	1,074
Institutional Holdings Percent	4.3%
Institutional Sold Previous 3 Months	1,445
Insider Holdings Date	-
Insider Bought Previous 3 Months	-
Insider Holdings Percent	0.0
Insider Sold Previous 3 Months	-
Insider Shares Owned	-

TRADING INFO
52 Week High	$ 29.89
52 Week Low	$ 4.59
52 Week High Change	$ 172.62
21 Day Moving Average	$ 29.3593
21 Day Extended Moving Average	$ 29.1757
50 Day Moving Average	$ 28.6807
50 Day Extended Moving Average	$ 26.7604
200 Day Moving Average	$ 13.1822
200 Day Extended Moving Average	$ 17.3538
10 Day Average Volume	31,653
20 Day Average Volume	32,187
30 Day Average Volume	33,272
50 Day Average Volume	63,807
Alpha	-0.048519
Beta	1.8442
Standard Deviation	0.312372
R2	0.101077
7 Day Price Change	$ -0.19
7 Day Percent Change	-0.65%
21 Day Price Change	$ -0.18
21 Day Percent Change	-0.61%
30 Day Price Change	$ -0.08
30 Day Percent Change	-0.27%
Month to Date Price Change	$ -0.08
Month to Date Percent Change	-0.27%
Quarter to Date Price Change	$ 13.38
Quarter to Date Percent Change	84.68%
180 Day Price Change	$ 22.65
180 Day Percent Change	347.06%
200 Day Price Change	$ 21.75
200 Day Percent Change	293.13%
Year to Date Price Change	$ 13.38
Year to Date Percent Change	84.68%

PROFITABILITY
EBIT Margin	-1,027.5%
EBITDA Margin	-1,012.8%
Pre-Tax Profit Margin	-2,187.1%
Profit Margin Count	0.0%
Gross Margin	76.7%
Profit Margin TOT	0.0%

INCOME STATEMENTS
Revenue	$ 2,393,394
Revenue Per Share	$ 0.8674
Revenue (3 Years)	$ 6.88
Revenue (5 Years)	$ -10.43

FINANCIAL STRENGTH
Price to Tangible Book	2.90
Total Debt To Equity	0.50
Int Coverage	-22.10
Current Ratio	8.40
Leverage Ratio	1.50
Quick Ratio	8.00
Long Term Debt To Capital	0.31

VALUATION MEASURES
PE Ratio	0.10
Enterprise Value	$ 58,684,309
Price to Sales	33.6286
Price to Free Cash	-4.20
PE High Last 5 Years	-0.10
Price To Book	2.90
Price To Cash Flow	0.00
PE Low Last 5 Years	-0.40
Price to Tangible Book	2.90

MANAGEMENT EFFECTIVENESS
Receivables Turnover	1.60
Invoice Turnover	0.30
Assets Turnover	0.00
Return Assets	-63.41
Return on Equity	-87.22
Return on Capital	-60.98

PROFILE INFO
Issue Type	CS
SEC Type	EQS
Auditor	GRANT THORNTON LLP
CEO	Fredericus A. Colen
Emplyoees	54
Last Audit	UE
CIK	0001399708
Industry	Medical Devices & Instruments
Sector	Healthcare
NAICS	Surgical and Medical Instrument Manufacturing(339112)

CONTACT INFO
Address	13562 Maycrest Way Suite 5138 Richmond, BC V6V 2J7
Website	https://www.neovasc.com
Facsimile	+1 604 270-4384
Telephone	+1 604 270-4344
Email	investors@neovasc.com

Boards:

Quotes:

NVCN